Theranos lab poses 'jeopardy to patient health': regulator

(Reuters) - Deficient practices at a lab operated by blood-testing startup Theranos pose "immediate jeopardy to patient health and safety," the U.S. government's Centers for Medicare & Medicaid Services said in a letter to the company released on Wednesday.